Copyright Reports & Markets. All rights reserved.

Global Exenatide Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Exenatide Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 1.2 ml/Cartridge
    • 1.3.3 2.4 ml/Cartridge
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Exenatide Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Pharmacy
  • 1.5 Global Exenatide Injection Market Size & Forecast
    • 1.5.1 Global Exenatide Injection Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Exenatide Injection Sales Quantity (2021-2032)
    • 1.5.3 Global Exenatide Injection Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 AstraZeneca
    • 2.1.1 AstraZeneca Details
    • 2.1.2 AstraZeneca Major Business
    • 2.1.3 AstraZeneca Exenatide Injection Product and Services
    • 2.1.4 AstraZeneca Exenatide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 AstraZeneca Recent Developments/Updates
  • 2.2 Amylin
    • 2.2.1 Amylin Details
    • 2.2.2 Amylin Major Business
    • 2.2.3 Amylin Exenatide Injection Product and Services
    • 2.2.4 Amylin Exenatide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Amylin Recent Developments/Updates
  • 2.3 Baxter Pharmaceutical
    • 2.3.1 Baxter Pharmaceutical Details
    • 2.3.2 Baxter Pharmaceutical Major Business
    • 2.3.3 Baxter Pharmaceutical Exenatide Injection Product and Services
    • 2.3.4 Baxter Pharmaceutical Exenatide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Baxter Pharmaceutical Recent Developments/Updates
  • 2.4 Lilly
    • 2.4.1 Lilly Details
    • 2.4.2 Lilly Major Business
    • 2.4.3 Lilly Exenatide Injection Product and Services
    • 2.4.4 Lilly Exenatide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Lilly Recent Developments/Updates
  • 2.5 Chenfei Pharmaceutical
    • 2.5.1 Chenfei Pharmaceutical Details
    • 2.5.2 Chenfei Pharmaceutical Major Business
    • 2.5.3 Chenfei Pharmaceutical Exenatide Injection Product and Services
    • 2.5.4 Chenfei Pharmaceutical Exenatide Injection Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Chenfei Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Exenatide Injection by Manufacturer

  • 3.1 Global Exenatide Injection Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Exenatide Injection Revenue by Manufacturer (2021-2026)
  • 3.3 Global Exenatide Injection Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Exenatide Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Exenatide Injection Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Exenatide Injection Manufacturer Market Share in 2025
  • 3.5 Exenatide Injection Market: Overall Company Footprint Analysis
    • 3.5.1 Exenatide Injection Market: Region Footprint
    • 3.5.2 Exenatide Injection Market: Company Product Type Footprint
    • 3.5.3 Exenatide Injection Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Exenatide Injection Market Size by Region
    • 4.1.1 Global Exenatide Injection Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Exenatide Injection Consumption Value by Region (2021-2032)
    • 4.1.3 Global Exenatide Injection Average Price by Region (2021-2032)
  • 4.2 North America Exenatide Injection Consumption Value (2021-2032)
  • 4.3 Europe Exenatide Injection Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Exenatide Injection Consumption Value (2021-2032)
  • 4.5 South America Exenatide Injection Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Exenatide Injection Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Exenatide Injection Sales Quantity by Type (2021-2032)
  • 5.2 Global Exenatide Injection Consumption Value by Type (2021-2032)
  • 5.3 Global Exenatide Injection Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Exenatide Injection Sales Quantity by Application (2021-2032)
  • 6.2 Global Exenatide Injection Consumption Value by Application (2021-2032)
  • 6.3 Global Exenatide Injection Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Exenatide Injection Sales Quantity by Type (2021-2032)
  • 7.2 North America Exenatide Injection Sales Quantity by Application (2021-2032)
  • 7.3 North America Exenatide Injection Market Size by Country
    • 7.3.1 North America Exenatide Injection Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Exenatide Injection Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Exenatide Injection Sales Quantity by Type (2021-2032)
  • 8.2 Europe Exenatide Injection Sales Quantity by Application (2021-2032)
  • 8.3 Europe Exenatide Injection Market Size by Country
    • 8.3.1 Europe Exenatide Injection Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Exenatide Injection Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Exenatide Injection Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Exenatide Injection Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Exenatide Injection Market Size by Region
    • 9.3.1 Asia-Pacific Exenatide Injection Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Exenatide Injection Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Exenatide Injection Sales Quantity by Type (2021-2032)
  • 10.2 South America Exenatide Injection Sales Quantity by Application (2021-2032)
  • 10.3 South America Exenatide Injection Market Size by Country
    • 10.3.1 South America Exenatide Injection Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Exenatide Injection Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Exenatide Injection Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Exenatide Injection Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Exenatide Injection Market Size by Country
    • 11.3.1 Middle East & Africa Exenatide Injection Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Exenatide Injection Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Exenatide Injection Market Drivers
  • 12.2 Exenatide Injection Market Restraints
  • 12.3 Exenatide Injection Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Exenatide Injection and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Exenatide Injection
  • 13.3 Exenatide Injection Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Exenatide Injection Typical Distributors
  • 14.3 Exenatide Injection Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Exenatide Injection market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    Exenatide injection, used to improve blood sugar control in patients with type 2 diabetes, is suitable for single use of metformin and sulfonylureas. And metformin combined with sulfonylureas, patients with poor blood sugar control.
    This report is a detailed and comprehensive analysis for global Exenatide Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Exenatide Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Exenatide Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Exenatide Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Exenatide Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Exenatide Injection
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Exenatide Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Amylin, Baxter Pharmaceutical, Lilly, Chenfei Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Exenatide Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    1.2 ml/Cartridge
    2.4 ml/Cartridge
    Market segment by Application
    Hospital
    Clinic
    Pharmacy
    Major players covered
    AstraZeneca
    Amylin
    Baxter Pharmaceutical
    Lilly
    Chenfei Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Exenatide Injection product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Exenatide Injection, with price, sales quantity, revenue, and global market share of Exenatide Injection from 2021 to 2026.
    Chapter 3, the Exenatide Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Exenatide Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Exenatide Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Exenatide Injection.
    Chapter 14 and 15, to describe Exenatide Injection sales channel, distributors, customers, research findings and conclusion.

    Buy now